These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7893592)

  • 1. Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.
    Coste J; Strauch G; Letrait M; Bertagna X
    Br J Clin Pharmacol; 1994 Nov; 38(5):474-9. PubMed ID: 7893592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects.
    Inder WJ; Livesey JH; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):7-13. PubMed ID: 8706296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined corticotropin-releasing hormone/lysine vasopressin test discloses a corticotroph phenotype.
    Bertagna X; Coste J; Raux-Demay MC; Letrait M; Strauch G
    J Clin Endocrinol Metab; 1994 Aug; 79(2):390-4. PubMed ID: 8045953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against changes in corticotroph CRF receptors in depressed patients.
    Young EA; Akil H; Haskett RF; Watson SJ
    Biol Psychiatry; 1995 Mar; 37(6):355-63. PubMed ID: 7772643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elevation of plasma beta-endorphin levels in major depression.
    Goodwin GM; Austin MP; Curran SM; Ross M; Murray C; Prentice N; Ebmeier KP; Bennie J; Carroll S; Dick H
    J Affect Disord; 1993 Dec; 29(4):281-9. PubMed ID: 8126314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropic hormone, beta-endorphin and cortisol responses to oCRH in unipolar depressed patients pretreated with dexamethasone.
    Maes M; Meltzer H; Cosyns P; Calabrese J; D'Hondt P; Blockx P
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1273-92. PubMed ID: 7863016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotroph axis sensitivity after exercise in endurance-trained athletes.
    Duclos M; Corcuff JB; Arsac L; Moreau-Gaudry F; Rashedi M; Roger P; Tabarin A; Manier G
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):493-501. PubMed ID: 9640417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of plasma immunoreactive adrenocorticotropin, beta-endorphin/beta-lipotropin, gamma-lipotropin and cortisol to experimentally induced pain in normal subjects.
    Güllner HG; Nicholson WE; Wilson MG; Bartter FC; Orth DN
    Clin Sci (Lond); 1982 Oct; 63(4):397-400. PubMed ID: 6286207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
    Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
    J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late feedback effects of hypothalamic-pituitary-adrenal axis hormones in healthy subjects.
    Posener JA; Schildkraut JJ; Williams GH; Schatzberg AF
    Psychoneuroendocrinology; 1998 May; 23(4):371-83. PubMed ID: 9695137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between beta-endorphin and beta-lipotrophin in human plasma using two-site immunoradiometric assays.
    Gibson S; Crosby SR; White A
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):445-53. PubMed ID: 8287571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-lipotropin/adrenocorticotropic hormone responses to corticotropin releasing hormone, hypoglycemia, metyrapone and dexamethasone in normal human subjects.
    Castro M; Moreira AC
    Braz J Med Biol Res; 1990; 23(11):1107-15. PubMed ID: 1966779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function.
    Berneis K; Staub JJ; Gessler A; Meier C; Girard J; Müller B
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5470-5. PubMed ID: 12466339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low dose ovine corticotropin-releasing hormone in humans: endocrine relationships and beta-endorphin/beta-lipotropin responses.
    Watson SJ; Lopez JF; Young EA; Vale W; Rivier J; Akil H
    J Clin Endocrinol Metab; 1988 Jan; 66(1):10-5. PubMed ID: 2826522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.